Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Insiders Buying These 4 Penny Stocks

Published 07/03/2022, 14:11
Updated 07/03/2022, 15:11
© Reuters.  Insiders Buying These 4 Penny Stocks

US crude oil futures surged to their strongest levels since 2008 early this morning, amid the risk of Western ban on Russia’s oil imports. Investors, meanwhile, focused on some notable insider trades

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Humanigen

  • The Trade: Humanigen, Inc. (NASDAQ: HGEN) CEO Cameron Durrant acquired a total of 40,000 shares at an average price of $2.34. To acquire these shares, it cost $93.6 thousand.
  • What’s Happening: Humanigen recently reported a FY21 net loss of $4.04 per share.
  • What Humanigen Does: Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective.
  • The Trade: 9 Meters Biopharma, Inc. (NASDAQ: NMTR) CEO John Temperato acquired a total of 100,000 shares at an average price of $0.56. The insider spent around $55.59 thousand to buy those shares.
  • What’s Happening: 9 Meters Biopharma recently reported a collaboration with NYU Langone Health investigating NM-102 as a potential treatment for an autoimmune disorder.
  • What 9 Meters Biopharma Does: 9 Meters Biopharma Inc is a clinical-stage biopharmaceutical company focused on rare and unmet needs in gastroenterology.

Lordstown Motors

  • The Trade: Lordstown Motors Corp. (NASDAQ: RIDE) CEO Daniel Ninivaggi acquired a total of 20,000 shares at an average price of $2.43. To acquire these shares, it cost around $48.59 thousand.
  • What’s Happening: Lordstown Motors recently reported Q4 earnings results and said it expects commercial production and sales of the Endurance of approximately 500 units in 2022 growing to as many as 2,500 units in 2023.
  • What Lordstown Motors Does: Lordstown Motors, founded in 2019, develops, manufactures, and sells Endurance, an electric full-size pickup truck for fleet customers.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
  • The Trade: Clover Health Investments, Corp. (NASDAQ: CLOV) Director Chelsea Clinton acquired a total of 100,000 shares at an average price of $2.53. The insider spent $252.53 thousand to buy those shares.
  • What’s Happening: Clover Health Investments recently reported better-than-expected Q4 sales results and issued FY22 sales guidance above estimates.
  • What Clover Health Investments Does: Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.